Imatinib mesylate and Infection - a phase IV clinical study of FDA data

Summary:

Infection is reported as a side effect among people who take Imatinib mesylate (imatinib mesylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Methotrexate, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Infection when taking Imatinib mesylate. It is created by eHealthMe based on reports of 4,127 people who have side effects when taking Imatinib mesylate from the FDA, and is updated regularly.

What is Imatinib mesylate?

Imatinib mesylate has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 4,178 Imatinib mesylate users. Check the latest studies of Imatinib mesylate.

What is Infection?

Infection is found to be associated with 2,503 drugs and 2,590 conditions by eHealthMe. Check the latest studies of Infection.

On Jul, 10, 2026

4,127 people reported to have side effects when taking Imatinib mesylate.
Among them, 35 people (0.85%) have Infection.

Could Imatinib mesylate cause Infection?

Among these 35 people:

How long have people been on Imatinib mesylate when they have Infection? *

What is the gender of people who have Infection when taking Imatinib mesylate? *

female: 51.61 %
male: 48.39 %

What is the age of people who have Infection when taking Imatinib mesylate? *

What are other drugs people take besides Imatinib mesylate? *

Cytarabine: 5 people, 14.29%
Methotrexate: 5 people, 14.29%
Dasatinib: 4 people, 11.43%
Hydrocortisone: 3 people, 8.57%
Dexamethasone: 3 people, 8.57%
Cyclophosphamide: 3 people, 8.57%
Acyclovir: 2 people, 5.71%
Metoprolol Tartrate: 2 people, 5.71%
Dexrazoxane Hydrochloride: 2 people, 5.71%
Montelukast Sodium: 2 people, 5.71%

What are other side effects people have besides Infection? *

Fever: 8 people, 22.86%
Nausea (feeling of having an urge to vomit): 4 people, 11.43%
Nausea And Vomiting: 4 people, 11.43%
Hypokalemia (low potassium): 3 people, 8.57%
Lymphoproliferative Disorder (a medical condition in which the immune system makes too many white blood cells): 3 people, 8.57%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 8.57%
Epstein-Barr Virus Infection: 3 people, 8.57%
Necrosis (the death of body tissue): 3 people, 8.57%
Electrolyte Imbalance: 3 people, 8.57%
Tinnitus (a ringing in the ears): 2 people, 5.71%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 11 people, 31.43%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 10 people, 28.57%
Gastrointestinal Stromal Tumor: 3 people, 8.57%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 5.71%
Respiratory Syncytial Virus Infection (viral disease of respiratory system): 2 people, 5.71%
Pain: 1 person, 2.86%
Nausea (feeling of having an urge to vomit): 1 person, 2.86%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.86%
Migraine (headache): 1 person, 2.86%
Malignant Glioma (cancerous tumour of brain a cancer tumour of uncertain origin that arises both in soft tissue and bone): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Imatinib mesylate and have Infection?

- Check whether Infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imatinib mesylate:

Imatinib mesylate (4,178 reports)

Infection treatments and more:

Infection (201,697 reports)

Browse all side effects of Imatinib mesylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infection:

Infection (2,503 drugs)

Browse all the conditions that are associated with Infection:

Infection (2,590 conditions)

Related publications that referenced our studies

O'rafferty C, McElligott F, Storey L, O'marcaigh A, Smith O, "Pneumatosis intestinalis and imatinib mesylate", Annals of hematology, 2014 Oct .
O'rafferty C, McElligott F, Storey L, O'marcaigh A, Smith O, "Pneumatosis intestinalis and imatinib mesylate", Annals of hematology, 2014 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on imatinib mesylate (the active ingredients of Imatinib mesylate) and Imatinib mesylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.